Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy

Asia Pacific Journal of Clinical Nutrition

Volumn 26, Issue 3, 2017, Pages 406-411

  Zhang, Ping Chuan ^a   Wu, Chang Rui ^b   Wang, Zhi Lun ^a   Wang, Li Yuan ^a   Han, Yue ^a   Sun, Shu Liu ^a   Li, Qing Shan ^a   Ma, Le ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Contrast sensitivity; Diabetic retinopathy; Lutein; Randomized controlled trial; Visual acuity

Indexed keywords

PLACEBO; XANTHOPHYLL;

AGED; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY;

AGED; CONTRAST SENSITIVITY; DIABETIC RETINOPATHY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUTEIN; MALE; MIDDLE AGED; PLACEBOS; VISUAL ACUITY;

EID: 85018975394     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.032016.13     Document Type: Article

References (32)

1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-36. doi: 10.1016/S0140-6736(09)621 24-3.
2. Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1:e339-49. doi: 10.1016/S2214-109X(13)70113-X.
3. Hassan SS, Bong DB, Premsenthil M. Detection of neovascularization in diabetic retinopathy. J Digit Imaging. 2012; 25:437-44. doi: 10.1007/s10278-011-9418-6.
4. Bressler NM, Beck RW, Ferris FL. Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med. 2011;365:1520-6. doi: 10.1056/NEJMct0908432.
5. Kaštelan S, Tomic M, Gverovic Antunica A, Salopek Rabatic J, Ljubic S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013;2013: 213130. doi: 10.1155/2013/213130.
6. Annadurai T, Thomas PA, Geraldine P. Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced experimental diabetes mellitus. Free Radic Res. 2013;47:793-803. doi: 10.3109/1071 5762.2013.823643.
7. Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:3941-8. doi: 10.1167/iovs.13-11598.
8. Böhm F, Edge R, Truscott TG. Interactions of dietary carotenoids with singlet oxygen (1O2) and free radicals: potential effects for human health. Acta Biochim Pol. 2012;59:27-30.
9. Brazionis L, Rowley K, Itsiopoulos C, O'Dea K. Plasma carotenoids and diabetic retinopathy. Br J Nutr. 2009;101: 270-7. doi: 10.1017/S0007114508006545.
10. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia. 2010;53:971-9. doi: 10.1007/s00125-009-1655-6.
11. Kowluru RA, Zhong Q, Santos JM, Thandampallayam M, Putt D, Gierhart DL. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab (Lond). 2014;11:8. doi: 10.1186/1743-7075-11-8.
12. Liu R, Wang T, Zhang B, Qin L, Wu C, Li Q, Ma L. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56:252-8. doi: 10.1167/iovs.14-15553.
13. Diabetic Retinopathy Study Group. Diabetic retinopathy study. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981;21:210-26.
14. Hong T, Mitchell P, Rochtchina E, Fong CS, Chia EM, Wang JJ. Long-term changes in visual acuity in an older population over a 15-year period: the Blue Mountains Eye Study. Ophthalmology. 2013;120:2091-9. doi: 10.1016/j. ophtha.2013.03.032.
15. Gil MA, Varón C, Cardona G, Vega F, Buil JA. Comparison of far and near contrast sensitivity in patients symmetrically implanted with multifocal and monofocal IOLs. Eur J Ophthalmol. 2014;24:44-52. doi: 10.5301/ejo.5000335.
16. Schmitz S, Dick HB, Krummenauer F, Schwenn O, Krist R. Contrast sensitivity and glare disability by halogen light after monofocal and multifocal lens implantation. Br J Ophthalmol. 2014;84:1109-12.
17. Wu Y, Tang L, Chen B. Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Oxid Med Cell Longev. 2014;2014: 752387. doi: 10.1155/2014/752387.
18. Wang Y, Shen D, Wang VM, Yu CR, Wang RX, Tuo J, Chan CC. Enhanced apoptosis in retinal pigment epithelium under inflammatory stimuli and oxidative stress. Apoptosis. 2012;17:1144-55. doi: 10.1007/s10495-012-0750-1.
19. Bian Q, Gao S, Zhou J, Qin J, Taylor A, Johnson EJ, Tang G, Sparrow JR, Gierhart D, Shang F. Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic Biol Med. 2012;53: 1298-307. doi: 10.1016/j.freeradbiomed.2012.06.024.
20. Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci. 2008;49:1645-51. doi: 10.1167/iovs.07-0764.
21. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216-30.
22. Cangemi FE. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol. 2007;7:3.
23. Dawczynski J, Jentsch S, Schweitzer D, Hammer M, Lang GE, Strobel J. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Graefes. Arch Clin Exp Ophthalmol. 2013;251:2711-23. doi: 10.1007/s00417-013-2376-6.
24. Koefoed VF, Baste V, Roumes C, Høvding G. Contrast sensitivity measured by two different test methods in healthy, young adults with normal visual acuity. Acta Ophthalmol. 2015;93:154-61. doi: 10.1111/aos.12487.
25. Hutchinson CV, Ledgeway T. Spatial summation of firstorder and second-order motion in human vision. Vision Res. 2010;50:1766-74. doi: 10.1016/j.visres.2010.05.032.
26. Rossi EA, Rangel-Fonseca P, Parkins K, Fischer W, Latchney LR, Folwell MA, Williams DR, Dubra A, Chung MM. In vivo imaging of retinal pigment epithelium cells in age related macular degeneration. Biomed Opt Express. 2013;4:2527-39. doi: 10.1364/BOE.4.002527.
27. Loskutova E, Nolan J, Howard A, Beatty S. Macular pigment and its contribution to vision. Nutrients. 2013;5:1962-9. doi: 10.3390/nu5061962.
28. Stringham JM, Garcia PV, Smith PA, McLin LN, Foutch BK. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort. Invest Ophthalmol Vis Sci. 2011;52:7406-15. doi: 10.1167/iovs.10-6699.
29. Subczynski WK, Wisniewska A, Widomska J. Location of macular xanthophylls in the most vulnerable regions of photoreceptor outer-segment membranes. Arch Biochem Biophys. 2010;504:61-6. doi: 10.1016/j.abb.2010.05.015.
30. Hammond BR, Fletcher LM, Elliott JG. Glare disability, photostress recovery, and chromatic contrast: relation to macular pigment and serum lutein and zeaxanthin. Invest Ophthalmol Vis Sci. 2013;54:476-81. doi: 10.1167/iovs.12-10411.
31. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000.
32. O'Neill ME, Carroll Y, Corridan B, Olmedilla B, Granado F, Blanco I, Van den Berg H, Hininger I, Rousell AM, Chopra M, Southon S, Thurnham DI. A European carotenoid database to assess carotenoid intakes and its use in a fivecountry comparative study. Br J Nutr. 2001;85:499-507.